2015 Q2/Global Life Sciences



Changes in rank are compared to 2015 Q1/Global Life Sciences. Since then, 4 sites entered the survey, 4 sites left the survey and 48 sites could not be included in the rankings (2 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
+ 42 Actelion 7.02
+ 3 Otsuka Pharmaceuticals Europe 6.91
+ 6 Nissan Chemical 6.82
+ 3 Kyorin Holdings 6.78
+ 187 Anika Therapeutics 6.76
same Kaken Pharmaceutical 6.74
- 4 ProStrakan Group 6.59
+ 4 Meda Pharmaceuticals 6.39
- 1 Taisho Pharmaceutical 6.36
+ 3 Galenica AG 6.31
+ 10 Ipsen UK 6.12
- 2 Lundbeck 6.08
+ 12 Wockhardt 6.04
- 3 Bavarian Nordic 5.96
same Diffusion Pharmaceuticals 5.81
+ 15 Nippon Chemiphar 5.76
+ 15 Servier 5.57
+ 17 Yakult UK 5.49
+ 15 Medivation 5.47
+ 6 Recordati 5.43
- 4 EISAI 5.42
+ 7 EISAI UK 5.33
same Mitsubishi Tanabe Pharma Europe Ltd 5.24
+ 16 CinnaGen 5.21
- 9 United Therapeutics 5.19
- 2 Santen 5.16
- 9 Debiopharm 5.15
+ 13 Zandu 5.14
+ 7 Dainippon Sumitomo 5.14
- 11 Gruenenthal 5.10
+ 43 Towa Pharmaceutical 4.91
- 5 Genzyme UK 4.90
+ 28 Astrazeneca Uk 4.89
- 12 Forest 4.89
+ 2 Valeant Europe 4.89
+ 6 Daiichi-Sankyo UK 4.87
+ 18 Kissei 4.86
+ 6 Boehringer Ingelheim 4.86
+ 6 Sanofi UK 4.84
+ 80 Agennix 4.84
+ 43 MediGene 4.84
+ 5 Galderma 4.78
- 23 Enzo Biochem 4.77
- 16 Covence 4.74
+ 5 Laboratoires Thea 4.74
+ 5 Servier UK 4.73
+ 52 Aptalis Pharma 4.71
+ 33 Pfizer UK 4.71
- 10 Stallergenes UK 4.71
+ 2 Sawai Pharmaceutical 4.70
- 18 Otsuka Pharmaceuticals 4.69
+ 59 Shire 4.68
+ 51 Hikma Pharmaceuticals 4.60
- 1 Laboratoires Thea UK 4.60
- 6 Mochida 4.58
+ 9 Alfa Wassermann 4.56
+ 14 Abbott Uk 4.56
+ 8 Stallergenes 4.52
+ 4 Nippon Kayaku 4.52
+ 34 Acorda Therapeutics 4.52
+ 8 Valeant Pharmaceuticals 4.51
+ 20 Onyx Pharmaceuticals 4.50
+ 22 Astellas Europe 4.48
- 5 Astrazeneca 4.48
+ 44 Mitsubishi Tanabe 4.48
new Biotest 4.48
+ 13 Genmab 4.46
- 11 Galapagos 4.40
- 11 Abbott 4.40
- 10 KRKA 4.40
+ 8 Novartis UK 4.38
- 24 BTG International 4.36
- 6 Teijin 4.32
- 28 CSL Behring UK 4.27
- 7 GlaxoSmithKline 4.26
+ 59 PDL BioPharma 4.23
- 23 Roche 4.22
+ 12 Menarini UK 4.22
+ 76 Pierre Fabre 4.20
- 10 Ipsen 4.15
- 4 Boehringer Ingelheim UK 4.15
+ 18 QLT 4.15
- 27 Apotex 4.14
+ 9 Astellas 4.14
- 2 Meiji Holdings 4.14
+ 36 Advaxis 4.13
+ 8 Alcon 4.12
+ 82 Perrigo 4.12
+ 82 Elan 4.12
+ 8 Bial Portela 4.10
- 2 Merz 4.07
- 16 Lilly UK 4.06
+ 41 Akorn 4.06
+ 72 Square Pharmaceuticals 4.05
+ 24 Bayer Schering Pharma 4.04
+ 37 Julphar 3.99
- 6 Daiichi-Sankyo 3.96
- 6 Ferozsons Laboratories 3.94
+ 37 Seattle Genetics 3.94
+ 6 CSL Behring 3.94
+ 27 Gilead Sciences 3.92
- 15 Avanir Pharmaceuticals 3.92
- 28 Impax Laboratories 3.91
+ 41 Pharma Nord 3.89
+ 2 Cerus 3.87
- 20 Stada 3.86
+ 53 ImmunoGen 3.86
+ 128 Bayer UK & Ireland 3.84
- 7 Kyowa Hakko Kirin 3.81
+ 31 Nektar Therapeutics 3.79
+ 53 Regeneron 3.78
+ 9 Jazz Pharmaceuticals 3.77
- 25 Eskayef Bangladesh Ltd 3.73
- 1 The Medicines Co 3.73
- 12 Vertex Pharmaceuticals 3.72
new Auxilium Pharmaceuticals 3.72
- 12 Pharmacosmos 3.70
+ 22 Hutchison China MediTech 3.70
+ 8 Orion Pharma 3.70
+ 32 Menarini 3.68
- 24 Vitrolife 3.66
- 21 Novartis 3.66
+ 1 Johnson & Johnson 3.64
+ 1 Piramel Enterprises 3.63
- 10 Asahi Kasei 3.62
new Elorac 3.62
+ 3 Exelixis 3.61
- 16 Toray Industries 3.61
+ 2 Array BioPharma 3.60
- 92 Fresenius Medical Care 3.58
+ 1 UCB Belgium 3.58
- 18 Allergan UK 3.55
- 17 Torrent Pharmacueticals 3.53
+ 42 Nova Nordisk UK 3.53
+ 42 Leo Pharma 3.53
+ 42 Leo Pharma UK 3.53
+ 21 Johnson & Johnson UK 3.53
- 20 Biotecnol 3.52
- 29 Senju Pharmaceutical 3.52
+ 10 Melior Discovery 3.50
- 4 Baxter Healthcare UK 3.50
- 19 China Pharmaceutical Group 3.49
- 5 Allergan 3.48
- 5 Roche UK 3.48
- 19 Targacept 3.44
+ 5 Yakult Honsha 3.42
- 3 ARIAD Pharmaceuticals 3.40
+ 14 Biocon 3.40
- 2 Pharmstandard 3.33
- 33 Elder Pharmaceuticals 3.33
- 150 Biogen Idec 3.32
+ 21 Progenics Pharmaceuticals 3.28
+ 4 Italfaraco 3.27
- 25 Endo Pharmaceuticals 3.26
+ 19 BioMarin Pharmaceutical 3.25
- 3 SOBI 3.23
- 8 Maxygen 3.21
- 12 Zambon 3.15
+ 32 Celgene 3.14
+ 41 Nova Nordisk 3.14
+ 2 Genus 3.13
- 98 MorphoSys 3.07
+ 33 Orchid Pharmaceuticals 3.06
+ 48 Esteve 3.04
- 9 Teva Pharmaceutical Industries Ltd 2.96
+ 6 Laboratorios Farmaceuticos ROVI 2.96
+ 22 SciClone Pharmaceuticals 2.95
+ 73 Anavex Life Sciences Corp 2.91
+ 21 Lilly 2.89
- 1 Isis Pharmaceuticals 2.89
- 3 Takeda 2.88
+ 7 ALK-Abello 2.87
+ 7 MannKind Corporation 2.86
- 32 Genzyme 2.80
- 16 Alexion Pharmaceuticals 2.78
- 11 Covidien 2.74
- 10 Handok 2.73
- 35 Actavis 2.72
+ 9 AEterna Zentaris 2.71
- 19 Purdue Pharma 2.70
+ 16 Ferring 2.68
+ 13 Panacea Biotec 2.68
+ 11 Sigma-Tau 2.68
+ 33 Paladin Labs 2.63
+ 25 Sun Pharmaceuticals 2.61
- 108 Sunpharma Europe 2.61
- 2 Sanofi 2.58
- 7 Dr Reddy's 2.57
+ 13 Taro Pharmaceutical Industries 2.55
+ 40 Bosnalijek 2.53
- 16 Salix 2.52
- 9 Maruho 2.52
+ 13 Chiesi 2.51
+ 13 Ligand Pharmaceuticals 2.51
- 9 Strides Arcolab 2.49
+ 13 Getz Pharma 2.45
- 15 Lupin Pharmaceuticals 2.45
- 50 Zentiva 2.45
+ 1 Medivir Group 2.43
+ 11 Unilab 2.43
- 8 Alkaloid 2.42
+ 12 Amgen UK 2.41
+ 12 Seikagaku 2.38
+ 12 Incepta Pharmaceuticals 2.38
- 7 Chugai - Pharma 2.36
- 3 Hisamitsu 2.34
- 3 Arena Pharmaceuticals 2.33
same Lavipharm 2.33
+ 9 UCB 2.32
+ 9 Bristol-Myers Squibb 2.32
+ 10 Cipla 2.32
+ 11 Idenix Pharmaceuticals 2.25
+ 11 Santen Europe 2.25
+ 24 Patheon 2.24
+ 17 Xoma 2.24
+ 11 Bionovo 2.19
+ 11 Par Pharmaceutical Companies 2.19
- 5 Kaneka 2.17
+ 12 Myriad Genetics 2.16
+ 13 Almirall Spain 2.15
+ 14 Veloxis Pharmaceuticals 2.10
- 35 Nippon Shinyaku 2.10
+ 17 Pfizer 2.07
- 4 Baxter International 2.06
new Glenmark Pharmaceuticals 2.04
same Simcere Pharmaceutical 2.03
- 2 Gedeon Richter 1.99
- 23 Aspen Pharmacare 1.99
- 157 Mylan 1.98
- 1 Alphapharm 1.93
+ 3 Faes Farma 1.88
+ 7 Beximco Pharmaceuticals 1.84
- 11 Merz UK 1.83
+ 3 Bristol-Myers Squibb UK 1.80
- 81 Perrigo UK 1.62
+ 7 Enzon Pharmaceuticals 1.55
+ 7 Hospira UK 1.37
+ 4 Ego Pharmaceuticals 1.20
+ 6 Hospira 1.11
+ 6 Sinovac Biotech 0.44
+ 6 Sinopharm 0.33